CHOLINE C-11

Peak

choline c-11

NDAINTRAVENOUSINJECTABLEPriority Review
Approved
Sep 2012
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

Radiopharmaceutical Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Indications (1)

prostate cancer
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers